- Home
- ACIU vs FOA Comparison
ACIU vs FOA Comparison
Compare ACIU & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | FOA |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | Switzerland | United States |
| Employees | N/A | 747 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 165.4M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ACIU | FOA |
|---|---|---|
| Price | $3.02 | $16.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $10.00 | ★ $29.75 |
| AVG Volume (30 Days) | ★ 330.1K | 74.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.44 |
| Revenue Next Year | $495.67 | $14.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.43 | $16.09 |
| 52 Week High | $4.00 | $29.58 |
Technical Indicators
Market Signals| Indicator | ACIU | FOA |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 19.65 |
| Support Level | $2.57 | N/A |
| Resistance Level | $3.92 | $23.57 |
| Average True Range (ATR) | 0.21 | 1.09 |
| MACD | 0.05 | -0.21 |
| Stochastic Oscillator | 72.56 | 3.73 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.